Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms - Nannya, Yasuhito; Tobiasson, Magnus; Sato, Shinya; Bernard, Elsa; Ohtake, Shigeki; Takeda, June; Creignou, Maria; Zhao, Lanying; Kusakabe, Manabu; Shibata, Yuhei; Nakamura, Nobuhiko; Watanabe, Mizuki; et al. (Blood advances, 2023)
Keywords: Azacitidine; Humans; Myelodysplastic Syndromes - drug therapy; Myelodysplastic Syndromes - genetics; Myeloid Neoplasia; Myeloproliferative Disorders; Neoplasms; Prognosis; Treatment Outcome